IFNG and lip and oral cavity carcinoma: Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by EGCG via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells.